DEA MATE - Activity 2 - Substance Use Screening and Treatment Approach in the ED – Opioids
- Non-member - Tier I - $35
- Non-member - Tier II - $35
- Non-member - Tier III - $35
- Non-member - Tier IV - $35
- Member - Tier I - Free!
- Member - Tier II - Free!
- Member - Tier III - Free!
- Member - Tier IV - Free!
Activity 2 of the ACMT DEA MATE Act Substance Use Disorder Educational package consists of 20-minute or less modules that were originally created for a SAMHSA-funded project called "Frontline: Training Emergency Medicine Residents and Medical Toxicology Fellows to Effectively Screen, Assess, and Treat Patients with Substance Use Disorder." The goal of this project was to provide the same level of training that a Medical Toxicologist might receive on how to provide consultation on SUD patients in the ED to a multidisciplinary emergency department team and staff. The idea being that expanded competency in the ED would result in more cohesive team treatment and better patient outcomes. This activity features highlights from the ACMT SAMHSA curriculum that have a specific focus on opioids. Check the course syllabus for more info.
Continuing Education credit for this activity is provided by AKH Inc., Advancing Knowledge in Healthcare. For more info, click here.
Length of Activity: ~ 2 hours
All Drug Enforcement Administration (DEA)-registered practitioners who treat patients with opioid or other substance use disorders, including physicians, nurse practitioners, physician assistants, and dentists.This requirement applies to new or renewing DEA registrants.
- Contrast aspects of addiction and physical dependence.
- Identify the best screening and assessment protocol that can be integrated into existing workflows of a busy Emergency Department.
- Identify the principles of motivational interviewing.
- Describe the pharmacology of Methadone and Naltrexone.
- Identify strategies used to beat a urine drug screen and how they can be detected.
There is no commercial support for this activity.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.
ACMT DEA MATE Act SUD Education
This course consists of 4 separate activities which satisfy the new, eight-hour education requirement issued by the Drug Enforcement Administration (DEA) to meet the conditions of the MATE Act for all registered practitioners on treating and managing patients with opioid or other substance use disorders.
- Activity 1: Clinical Updates on Substance Use Disorder (2.75 CR)
- Activity 2: Substance Use Screening and Treatment Approach in the ED – Opioids (1.50 CR)
- Activity 3: Substance Use Screening and Treatment Approach in the ED – Non-Opioids (1.25 CR)
- Activity 4: Highlights from Addiction Toxicology Case Conferences (3.0 CR)
Attendees can register for each activity separately as meets their needs or interest, or sign up for the 4-activity package (a $40 savings!). When taken together, the 4 activities add up to meet the full 8 credits required to maintain DEA licensure.
Total Activity Length: around 2 hours (110 minutes)
SAMHSA Module: Substance Use Disorder 101: Understanding the Difference Between Addiction and Physical Dependence | 17 min
Kurt Kleinschmidt, MD, FACMT, FASAM, Professor of Emergency Medicine, Division of Medical Toxicology, UT Southwestern Medical Center; Medical Director, Perinatal Intervention Program, Parkland Health and Hospital System, Dallas, TX
In this module, the speaker contrasts aspects of addiction and physical dependence, defines addiction, and determines the disease treated by detoxification.
SAMHSA Module: Screening for and Assessment of Substance Use Disorders in the ED | 19 min
Alaina R. Steck, MD, FACMT, FASAM, Associate Professor of Emergency Medicine, Emory University, Atlanta, GA
In this module, the speaker identifies the best screening and assessment protocol that can be integrated into existing workflows of a busy Emergency Department as well as discusses how to implement universal screening for SUD in Emergency Department patients.
SAMHSA Module: Motivational Interviewing in the ED | 16 min
Henry D. Swoboda, MD, Assistant Professor of Emergency Medicine & Psychiatry, Rush University, Chicago, IL
This module focuses on motivational interviewing, defining its principles and goals.
SAMHSA Module: Methadone | 20 min
Timothy Wiegand, MD, FACMT, FAACT, DFASAM, Associate Professor of Emergency Medicine and the Director of Toxicology and the Toxicology/Addiction Consult Service, Strong Memorial Hospital, University of Rochester Medical Center, Rochester, NY
In this module, the speaker describes important elements related to the history of methadone use for the treatment of opioid use disorder and chronic pain in the United States. He describes the pharmacology of methadone, identifies methadone PEARLS for the Emergency Department, and discusses common medico-legal issues with methadone.
SAMHSA Module: Extended Release Intramuscular Naltrexone in Opioid Use Disorder Treatment | 21 min
Henry D. Swoboda, MD, Assistant Professor of Emergency Medicine, Rush University, Chicago, IL
The speaker in this module focuses on the patient who is a likely candidate for medicated assisted abstinence. He contrasts the risks and benefits of naltrexone compared to other medications and goes through the indications for naltrexone. Lastly, he identifies the common side effects of naltrexone that all healthcare providers should be aware of.
SAMHSA Module: Urine Drug Testing: Interpretation Basics and Pitfalls | 17 min
Rachel S. Wightman, MD, Director of Medical Toxicology Education, Department of Emergency Medicine, Assistant Professor of Emergency Medicine, Alpert Medical School of Brown University, Providence, RI
In this module, the speaker review the advantages and disadvantages of urine screening. She identifies at least two reasons for conducting a urine screen and discusses when a confirmatory test should be conducted. Lastly, she identifies various strategies used to beat a drug screen and how they can be detected.
None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships listed for these individuals have been mitigated.
AKH Reviewers and Planners
Dorothy Caputo, MA, BSN, RN, VP, Healthcare Continuing Education and Operations
Bernadette Makar, MSN, APRN-BC, NP-C
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
- 90-day access to the course from date of purchase
- Continuing Education Credits for: Physicians, Nurse Practitioners, Physician Assistants or Dentists. Click on the "Continuing Education" tab for details.
The accreditation of this activity is valid until June 1, 2024.
Interested in becoming an ACMT Member? Contact our Membership Manager at email@example.com.
Learn more at: www.acmt.net/membership
Refunds and Cancellations
For questions regarding our refund and cancellation policy, please email us at firstname.lastname@example.org.
Package Options - Discounted Rates!
Purchase all 4 ACMT DEA MATE Act Education activities at the same time -- a $40 savings! When packaged together, the 4 activities award 8.50 credits, more than the requirement needed to maintain DEA licensure.
Once you have completed your registration:
- Click on the Contents tab. This is where you will be able to see all lectures and required content for this course.
- Watch all recordings. Learners will not be able to fast forward or increase the video speed. Learners will be required to watch at least 3/4 of the video before it will be marked as complete and you can move on to the next.
- Complete Post-Test. Learners will have unlimited attempts and the test requires 70% to pass.
- Complete Survey. This survey is required by our CE provider and must be completed in full.
- Download Continuing Education Certificate. Select which certificate to download. Your options are: Physician, Physician Assistant, Nurse Practitioner, or Dentist.
Computer or Other Internet-Enabled Device; Internet Connection; Browser.
This activity is Web-based/Web on Demand.
Need Assistance or Have Questions?
For assistance logging in, accessing content, purchasing or completing Continuing Education credits, or for other questions, please contact us at email@example.com or visit our FAQ page.
If you have questions regarding the CE of this activity, please contact AKH Inc. at JGoldman@akhcme.com.
If you are in need of accessible learning accommodations, please contact firstname.lastname@example.org for additional assistance.
Continuing Education credit for this activity is provided by AKH Inc., Advancing Knowledge in Healthcare.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credit for learning and change.
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. Approval is valid until June 1, 2024. PAs should only claim credit commensurate with the extent of their participation.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 1.5 contact hour(s) (which includes 1.0 hour(s) of pharmacology).
AKH Inc., Advancing Knowledge in Healthcare is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.
AKH Inc., Advancing Knowledge in Healthcare designates this activity for 1.5 continuing education credits.
Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.
|Access Date||Quiz Result||Score||Actions|